A hospital clinical office building and outpatient clinic building
Dclemens1971 - CC BY 4.0/Wikimedia Commons

Medicare Patients Who Get Drugs at Hospital Outpatient Clinics Are Expected to Save an Average of $900 in 2027 Under a New CMS Rule

Seniors on Original Medicare who get infusions, injections and other drugs at a hospital outpatient clinic are expected to pay less for them next year. Under a final rule issued Nov. 4, the Centers for Medicare & Medicaid Services says those patients will save an average of $900 on drug costs in 2027.

The savings come from a sharp cut in what Medicare pays hospitals for drugs bought at a discount under the federal 340B program. Because Medicare patients typically owe a share of what Medicare pays, a lower payment means a lower bill for the patient. Major hospital groups oppose the change.

Where the $900 Average Comes From

In its announcement of the final rule, CMS said beneficiaries who receive a qualifying drug in a hospital outpatient department are expected to save an average of $900 in drug costs in calendar year 2027.

Across all patients, CMS estimates the change will cut what Original Medicare beneficiaries pay for these drugs by about $1.1 billion, and save taxpayers about $4.35 billion, for a total drop in drug spending of roughly $5.45 billion in the first year.

The $900 is an average for patients who get a qualifying drug, not a flat amount for everyone on Medicare. What any one patient saves depends on which drugs they receive, how often, and whether the hospital bought them through the 340B program.

Why Medicare’s Payment Cut Lowers Patient Bills

Under Original Medicare, outpatient hospital care falls under Part B. According to Medicare.gov, patients first pay the Part B deductible and then usually owe 20% of the Medicare-approved amount, along with a hospital copayment for each outpatient service.

That 20% is tied to what Medicare pays. When the approved amount for a drug falls, the patient’s share falls with it.

The CMS fact sheet on the rule says Medicare will pay for drugs that hospitals bought through the 340B program at the drug’s average sales price minus 28% in 2027. Until now, those drugs were paid at average sales price plus 6%, according to Fierce Healthcare. CMS had proposed an even deeper cut, to average sales price minus 33.4%.

CMS said its own survey found hospitals buy these drugs at an average cost “significantly below” the average sales price, which is the basis for the lower payment.

Other Changes That Could Trim Costs

The rule also changes how Medicare pays for some scans. Off-campus hospital departments will be paid the lower physician office rate for certain imaging done without contrast. CMS estimates that saves $260 million in 2027, and Fierce Healthcare reported that about $70 million of that is lower cost-sharing for patients.

CMS is also removing 637 more services from Medicare’s “inpatient only” list, the second year of a three-year phase-out. That allows more procedures to be done on an outpatient basis, which CMS says often lowers what patients owe.

Hospitals as a whole still get a raise. The fact sheet lists a 2.3% payment update for hospital outpatient departments and ambulatory surgical centers that meet quality reporting rules.

Hospitals Warn of Strain on Care

The American Hospital Association strongly opposes the 340B change. Ashley Thompson, the group’s senior vice president for public policy analysis and development, said in a Nov. 4 statement that the AHA is “deeply concerned about CMS’ continued assault on the 340B program.” She said the lower rates and a faster clawback of funds “will further stress hospitals’ ability to care for their patients.”

Other hospital groups, including the Association of American Medical Colleges, warned that the cuts fall hardest on nonprofit and public hospitals that serve low-income patients, Fierce Healthcare reported. The Federation of American Hospitals took the opposite view, saying the changes will lower seniors’ out-of-pocket costs.

The 340B program lets hospitals that serve many low-income patients buy outpatient drugs at steep discounts. The AHA argues that hospital outpatient departments treat sicker and more complex patients, including people with disabilities and those in low-income and rural communities, according to Fierce Healthcare.

What Medicare Patients Should Know for 2027

The savings apply to Original Medicare. People in Medicare Advantage plans pay under their plan’s own rules, so their costs depend on how the plan sets its copays for outpatient drugs.

These lower drug payments land in the same year the standard Part B premium rises to $209.40 a month, as covered in the 2027 Part B premium story. Separately, Medicare’s negotiated prices for 15 more drugs, including Ozempic, take effect Jan. 1, as detailed in the Ozempic price change.

Medicare.gov also notes that Part B generally does not cover “self-administered drugs,” the kind patients normally take on their own, when they are given in an outpatient setting, although some injectables that are part of a procedure are covered. The $900 average applies to qualifying drugs that Part B pays for in hospital outpatient departments.

This article was produced with AI assistance and edited for accuracy against the sources linked above.

Image: Dclemens1971 – CC BY 4.0/Wikimedia Commons

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *